Performance of common genetic variants in breast-cancer risk models
- PMID: 20237344
- PMCID: PMC2921181
- DOI: 10.1056/NEJMoa0907727
Performance of common genetic variants in breast-cancer risk models
Erratum in
- N Engl J Med. 2010 Dec 2;363(23):2272
Abstract
Background: Genomewide association studies have identified multiple genetic variants associated with breast cancer. The extent to which these variants add to existing risk-assessment models is unknown.
Methods: We used information on traditional risk factors and 10 common genetic variants associated with breast cancer in 5590 case subjects and 5998 control subjects, 50 to 79 years of age, from four U.S. cohort studies and one case-control study from Poland to fit models of the absolute risk of breast cancer. With the use of receiver-operating-characteristic curve analysis, we calculated the area under the curve (AUC) as a measure of discrimination. By definition, random classification of case and control subjects provides an AUC of 50%; perfect classification provides an AUC of 100%. We calculated the fraction of case subjects in quintiles of estimated absolute risk after the addition of genetic variants to the traditional risk model.
Results: The AUC for a risk model with age, study and entry year, and four traditional risk factors was 58.0%; with the addition of 10 genetic variants, the AUC was 61.8%. About half the case subjects (47.2%) were in the same quintile of risk as in a model without genetic variants; 32.5% were in a higher quintile, and 20.4% were in a lower quintile.
Conclusions: The inclusion of newly discovered genetic factors modestly improved the performance of risk models for breast cancer. The level of predicted breast-cancer risk among most women changed little after the addition of currently available genetic information.
2010 Massachusetts Medical Society
Figures
Comment in
-
A tiny step closer to personalized risk prediction for breast cancer.N Engl J Med. 2010 Mar 18;362(11):1043-5. doi: 10.1056/NEJMe0912474. N Engl J Med. 2010. PMID: 20237351 No abstract available.
Similar articles
-
Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.J Natl Cancer Inst. 2010 Nov 3;102(21):1618-27. doi: 10.1093/jnci/djq388. Epub 2010 Oct 18. J Natl Cancer Inst. 2010. PMID: 20956782 Free PMC article.
-
Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women.J Natl Cancer Inst. 2010 Jul 7;102(13):972-81. doi: 10.1093/jnci/djq170. Epub 2010 May 18. J Natl Cancer Inst. 2010. PMID: 20484103 Free PMC article.
-
Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk.J Natl Cancer Inst. 2008 Jul 16;100(14):1037-41. doi: 10.1093/jnci/djn180. Epub 2008 Jul 8. J Natl Cancer Inst. 2008. PMID: 18612136 Free PMC article.
-
Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women.Breast Cancer Res. 2012 Jan 23;14(1):R17. doi: 10.1186/bcr3101. Breast Cancer Res. 2012. PMID: 22269215 Free PMC article.
-
The current state of genetic risk models for the development of kidney cancer: a review and validation.BJU Int. 2022 Nov;130(5):550-561. doi: 10.1111/bju.15752. Epub 2022 May 7. BJU Int. 2022. PMID: 35460182 Free PMC article. Review.
Cited by
-
Breast cancer risk assessment based on susceptibility genes and polygenic risk score in Vietnamese women.BJC Rep. 2024 Oct 8;2(1):80. doi: 10.1038/s44276-024-00100-7. BJC Rep. 2024. PMID: 39516406 Free PMC article.
-
Plasma metabolomics profiles and breast cancer risk.Breast Cancer Res. 2024 Oct 9;26(1):141. doi: 10.1186/s13058-024-01896-5. Breast Cancer Res. 2024. PMID: 39385226 Free PMC article.
-
Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank.Cancer Epidemiol Biomarkers Prev. 2024 Jun 3;33(6):812-820. doi: 10.1158/1055-9965.EPI-23-1432. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 38630597 Free PMC article.
-
The Relationship between VDR Gene Polymorphisms Bsm1 and Apa1 with Breast Cancer Risk.Glob Med Genet. 2024 Mar 4;11(1):69-75. doi: 10.1055/s-0044-1779040. eCollection 2024 Jan. Glob Med Genet. 2024. PMID: 38440355 Free PMC article.
-
Novel breast cancer susceptibility loci under linkage peaks identified in African ancestry consortia.Hum Mol Genet. 2024 Apr 8;33(8):687-697. doi: 10.1093/hmg/ddae002. Hum Mol Genet. 2024. PMID: 38263910
References
-
- Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151:716–26. - PubMed
-
- ACOG practice bulletin no. 103: hereditary breast and ovarian cancer syndrome. Obstet Gynecol. 2009;113:957–66. - PubMed
-
- Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879–86. - PubMed
-
- Gail MH, Benichou J. Validation studies on a model for breast cancer risk. J Natl Cancer Inst. 1994;86:573–5. Erratum, J Natl Cancer Inst 1994;86:803. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical